Filtered By:
Condition: Diabetes
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 71 results found since Jan 2013.
How People With Diabetes Can Lower Stroke Risk
After spending nearly two decades trying to manage her Type 2 diabetes, Agnes Czuchlewski landed in the emergency room in 2015, with news that she’d just experienced a heart attack. She also learned that she had metabolic syndrome, a cluster of conditions that includes diabetes but also brings higher risk of heart disease and stroke.
“Because I needed to lose quite a bit of weight when I was first diagnosed, I was focused on the number I saw on the scale, and then on my blood-sugar numbers,” recalls Czuchlewski, 68, who lives in New York City. “I didn’t realize other numbers came into play, li...
Source: TIME: Health - November 10, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Disease healthscienceclimate Source Type: news
The Racial Gap in U.S. Stroke Deaths Got Worse During the Pandemic
NEW YORK — The longstanding racial gap in U.S. stroke death rates widened dramatically during the COVID-19 pandemic, government researchers said Thursday.
Stroke death rates increased for both Black and white adults in 2020 and 2021, according to the Centers for Disease Control and Prevention study. But the difference between the two groups grew about 22%, compared with the five years before the pandemic.
“Any health inequity that existed before seems to have been made larger during the pandemic,” said Dr. Bart Demaerschalk, a stroke researcher at the Mayo Clinic in Phoenix who was not involved in the new...
Source: TIME: Health - April 20, 2023 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Depression Could Double Stroke Risk In People Over 50
Published: May 13, 2015 04:35pm ET by LiveScience.
People who have depression for a long time may be at increased risk for stroke, a new study suggests.
Researchers found that adults ages 50 and older who had symptoms of depression that lasted more than two years were twice as likely to have a stroke in the following two years, compared with men and women of similar age with no signs of depression.
"The exact pathway through which depressive symptoms may lead to stroke remains unclear, and is an important area for future research," said study lead author Paola Gilsanz, a postdoctoral fellow at the Harvard T.H. Cha...
Source: Science - The Huffington Post - May 14, 2015 Category: Science Source Type: news
Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit using...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revascularization, a c...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need for data in ...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
What to Know if Your Doctor Put You on Statins to Lower Cholesterol
High cholesterol is a prime example of having too much of a good thing. Our bodies naturally make this substance in the liver and then transport it throughout the body for multiple functions, including hormone regulation, cell tissue regeneration, and vitamin absorption. When the system is working well, cholesterol can boost overall health. But when a certain type called low-density lipoprotein—LDL, sometimes dubbed the “bad” kind—is overproduced, not only does it block the “good” kind called high-density lipoprotein (HDL), but it can also begin to accumulate in the arteries and form thi...
Source: TIME: Health - January 25, 2023 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized healthscienceclimate heart health Source Type: news
Is Your Heart Older Than You? Maybe, Says New Report
NEW YORK (AP) — Your heart might be older than you are.
A new government report suggests age is just a number — and perhaps not a very telling one when it comes to your risk of heart attack or stroke.
The Centers for Disease Control and Prevention report takes a new approach to try to spur more Americans to take steps to prevent cardiovascular disease.
CDC scientists estimated the average “heart age” of men and women in every state, based on risk factors like high blood pressure, obesity, and whether they smoke or have diabetes. Then it compared the numbers to average actual ages.
AVERAGE PREDICTED HEART AG...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 2, 2015 Category: Consumer Health News Authors: miketoole Tags: Health Local News CDC Framingham Source Type: news
7 Myths About Cholesterol, Debunked
You may not recall every lab value from your last physical, but you probably remember one: Your cholesterol level.
If it’s higher than ideal, you’re not alone. According to the U.S. Centers for Disease Control and Prevention, between 2015 and 2018, almost 12% of U.S. adults ages 20 and up had high total cholesterol, defined as above 240 mg/dL. The type that physicians mostly worry about is LDL (or “bad”) cholesterol, which is one component of that total.
Why do doctors care so much about cholesterol? First, “it predicts risk,” says Dr. Jeffrey Berger, a cardiologist and director of the C...
Source: TIME: Health - June 19, 2023 Category: Consumer Health News Authors: Katherine Hobson Tags: Uncategorized freelance healthscienceclimate heart health Source Type: news
Ezetimibe provides particular benefit in patients with diabetes and recent acute coronary syndrome
(Brigham and Women's Hospital) According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Acute coronary syndrome, which includes heart attack and unstable angina, a condition that can lead to a heart attack, are among the leading causes of death and disability worldwide. In addition to lifestyle changes, medications that lower blood cholesterol are helpful in preventing future cardiac and vascular events, including heart attack and stroke.
Source: EurekAlert! - Medicine and Health - August 30, 2015 Category: Global & Universal Source Type: news
More Than A Third Of Americans Don't Get Enough Sleep
We spend about one-third of our life doing it, but more than one in three Americans still aren’t getting enough sleep, according to a new government report. In their first study of self-reported sleep length, the U.S. Centers for Disease Control and Prevention found that 34.8 percent of American adults are getting less than seven hours of sleep -- the minimum length of time adults should sleep in order to reduce risk of obesity, diabetes, high blood pressure, stroke, mental distress, coronary heart disease and early death. In total, an estimated 83.6 million adults in the U.S. are sleep deprived, the CDC repor...
Source: Science - The Huffington Post - February 18, 2016 Category: Science Source Type: news
U.S. Life Expectancy Falls As More People Die From Illnesses
Rising mortality from a variety of illnesses caused life expectancy for Americans to drop in 2015 for the first in more than two decades, according to a National Center For Health Statistics study released Thursday.
The drop of 0.1 percent was small ― life expectancy at birth was 78.8 years in 2015, compared with 78.9 years in 2014. But it reverses a long trend, and the factors that led to it are worth looking at.
Diseases caused more deaths in 2015 than they did the year before. Age-adjusted death rates increased overall by 1.2 percent, from 724.6 deaths per 100,000 standard population in 2014 to 733.1 in...
Source: Healthy Living - The Huffington Post - December 8, 2016 Category: Consumer Health News Source Type: news
Why You Should Start Thinking About Your Cholesterol Earlier
High cholesterol is known to be one of the primary risk factors for heart disease, since it can contribute to plaque buildup in the arteries. But even though the U.S. Centers for Disease Control and Prevention recommends regular cholesterol testing starting around age 20, many Americans don’t give cholesterol—or heart disease, for that matter—much thought until later in life.
A new modeling study published in the Lancet gives extra reason not to put off cholesterol screening and treatment. It confirms that high blood levels of “bad” (or non-HDL) cholesterol are associated with a greater risk o...
Source: TIME: Health - December 4, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Research Source Type: news
The COVID-19 Pandemic Kept Thousands of People From Getting Urgent Medical Care, CDC Says
When COVID-19 lockdowns were first announced in March, doctors also urged patients to postpone all but the most necessary procedures and appointments to save space in hospitals. Many elective surgeries were pushed off, and routine care was mostly moved online.
From the beginning, doctors feared these difficult but necessary precautions would have an unintended consequence: Dissuading from people who actually did need immediate care from getting it. Now, new data from the U.S. Centers for Disease Control and Prevention (CDC) confirm that concern.
( function() {
var func = function() {
var iframe = document.ge...
Source: TIME: Health - June 22, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Cinnamon May Slow Progression To Type 2 Diabetes, Boston Study Finds
(CNN) — Cinnamon may improve blood sugar control in people with a condition known as prediabetes and may slow the progression to type 2 diabetes, according to a new pilot study of 51 people with elevated blood sugars.
“We are looking for safe, durable and cost-effective approaches to reduce the progression from prediabetes to type 2 diabetes,” said study author Dr. Giulio Romeo, a staff physician at Boston’s Joslin Diabetes Center and the division of endocrinology at Beth Israel Deaconess Medical Center. The study published Tuesday in the Journal of the Endocrine Society.
“Our 12-week study sh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 21, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Cinnamon CNN Diabetes Source Type: news
